ENDSULIN

Endsulin is an early-stage biotechnology company with an extraordinary mission: to end dependence on insulin for T1DM patients so they can assert their independence and live a life no longer defined by diabetes... Endsulin is developing a revolutionary genetic therapy for T1DM that with a single administration would restore the body's own ability to produce and regulate insulin. Our goal is to deliver a patented genetic factor that will "switch on" new insulin-producing cells to confer years - and perhaps a lifetime - of freedom from injecting artificial insulin, realizing the goal that has eluded researchers since the discovery of insulin.